Skip to main content
DrugPrice

Various, Drug Prices & Medicare Spending

Various manufactures 33 drugs tracked by Medicare Part D with total spending of $4.0B.

33
Drugs Tracked
$4.0B
Medicare Spending
$12.51
Avg Cost/Claim
100%
Have Generics

Various Drugs, Ranked by Medicare Spending

#DrugGeneric NameCost/ClaimGeneric?
1TacrolimusTacrolimus$139.00Yes
2LevothyroxineLevothyroxine Sodium$8.00Yes
3MycophenolateMycophenolate Mofetil$94.00Yes
4LisinoprilLisinopril$6.00Yes
5OxycodoneOxycodone Hydrochloride$27.00Yes
6VancomycinVancomycin Hydrochloride$144.00Yes
7MetforminMetformin Hydrochloride$4.00Yes
8HydrocodoneHydrocodone/Acetaminophen$10.00Yes
9Carbidopa-LevodopaCarbidopa/Levodopa$17.00Yes
10TrazodoneTrazodone Hydrochloride$8.00Yes
11SpironolactoneSpironolactone$14.00Yes
12DoxycyclineDoxycycline Hyclate$14.00Yes
13MorphineMorphine Sulfate$25.00Yes
14DiltiazemDiltiazem Hydrochloride$19.00Yes
15HydrochlorothiazideHydrochlorothiazide$4.00Yes
16AtenololAtenolol$10.00Yes
17TramadolTramadol Hydrochloride$6.00Yes
18AllopurinolAllopurinol$10.00Yes
19CephalexinCephalexin$10.00Yes
20AmoxicillinAmoxicillin$8.00Yes
21NitrofurantoinNitrofurantoin Monohydrate$14.00Yes
22PrednisonePrednisone$6.00Yes
23VerapamilVerapamil Hydrochloride$18.00Yes
24RamiprilRamipril$18.00Yes
25ClonidineClonidine$14.00Yes
26PropranololPropranolol Hydrochloride$18.00Yes
27BuspironeBuspirone Hydrochloride$14.00Yes
28MirtazapineMirtazapine$14.00Yes
29OxybutyninOxybutynin Chloride$18.00Yes
30CalcitriolCalcitriol$36.00Yes
31LithiumLithium Carbonate$48.00Yes
32AmitriptylineAmitriptyline Hydrochloride$10.00Yes
33CitalopramCitalopram Hydrobromide$10.00Yes

Frequently Asked Questions

Various manufactures 33 drugs tracked by Medicare Part D, with total annual spending of $4.0B.

Vancomycin (Vancomycin Hydrochloride) is the most expensive at $144.00 per claim.

33 of 33 Various drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.

this entity is one of the data points covered by this site’s U.S. Medicare prescription-drug pricing dataset. The detail above comes directly from CMS Medicare Part D Drug Spending data; the context that follows situates the headline numbers against the broader distribution across U.S. prescription drugs.

Every number on this page links back to CMS Medicare Part D Drug Spending data; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.

Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within U.S. prescription drugs. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.

Source: CMS Medicare Part D Spending, 2026.